Advanced NSCLC Targeted Therapy - ALK
Sort by:
GRACE
Reading a Molecular Testing Report in Lung Cancer
FEATURING
Karen Yun
- 35 views
- April 1, 2025
- 1
GRACE
ALK, ROS1, and RET in NSCLC: Pushing the Boundaries of Targeted Therapies
FEATURING
Christine Bestvina
- 38 views
- April 1, 2025
- 1
Scripps Health
Optimal Management of Stage IV ALK-Rearranged NSCLC
FEATURING
Kamya Sankar
- 16 views
- March 20, 2025
Scripps Health
ALK-Rearranged NSCLC: Case Discussions - Non-Smokers With No PMH
FEATURING
Kamya Sankar
- 8 views
- March 20, 2025
Scripps Health
Future Direction of ALK-Rearranged NSCLC Management
FEATURING
Kamya Sankar
- 5 views
- March 20, 2025
Scripps Health
Incidence and Biology of ALK-Rearranged NSCLC
FEATURING
Kamya Sankar
- 4 views
- March 19, 2025
OncoAlert
Early Stage NSCLC: Adjuvant & Neoadjuvant Chemo + IO, Adjuvant Alectinib, Osimertinib After CRT in Stage 3 Disease
FEATURING
Gilberto Lopes
- 29 views
- March 13, 2025
- 2
OncoAlert
Updates in NSCLC: Top Trial Highlights From 2024 (LAURA, CROWN, REACH PC, and MARIPOSA-2)
FEATURING
Charu Aggarwal
- 25 views
- March 13, 2025
- 1
Total Health
ALK Inhibitors & KRAS Targeted Therapies in NSCLC
FEATURING
Fred Hirsch
- 34 views
- March 8, 2025
GRACE
Targeted Therapies for NSCLC: Overview & Surgically Resected Disease
FEATURING
Angel Qin
- 17 views
- February 28, 2025
GRACE
Targeted Therapies in Non-Metastatic Lung Cancer
FEATURING
Angel Qin
- 29 views
- February 28, 2025
OncoPharm
Latest FDA Approvals: Ensartinib, Subcutaneous Nivolumab, and Encorafenib for NSCLC, CRC & Melanoma
FEATURING
John Bossaer
- 24 views
- February 5, 2025
Memorial Sloan Kettering Cancer Center
Role of Surgery in Locally Advanced NSCLC
FEATURING
Katherine Gray
- 278 views
- January 17, 2025
- 4
Nebraska Oncology Society
Year in Review 2024 - Targeted Therapy for NSCLC
FEATURING
Joseph Murray
- 243 views
- January 5, 2025
- 1
Fox Chase Cancer Center
Progress in Targeting ALK and ROS1 in NSCLC
FEATURING
Melina Marmarelis
- 77 views
- December 16, 2024
UChicago Medicine
Biomarker Testing in aNSCLC: Current Guidelines, Gaps, and Impact on Treatment Outcomes
FEATURING
Rajat Thawani
- 190 views
- December 6, 2024
- 6
Shirish Gadgeel
Advancing Treatment Strategies for ALK-Positive Advanced NSCLC
- 43 views
- November 27, 2024
- 1
Lung Cancer Europe (LuCE)
Targeted Therapy and Oncogene Addiction in Lung Cancer: Understanding EGFR and ALK Pathways
FEATURING
Benjamin Besse
- 47 views
- November 11, 2024
Total Health
Selected Targeted Therapies in NSCLC - Advances in Thoracic Oncology
FEATURING
Jason Porter
- 30 views
- October 29, 2024
Springer Healthcare IME
The Era of Precision Oncology
FEATURING
Jaime Schneider
- 161 views
- October 29, 2024
- 1
Springer Healthcare IME
New Frontiers in Oncology: Advanced Diagnostics and Therapeutics
FEATURING
Solange Peters
- 223 views
- October 29, 2024
- 6
Springer Healthcare IME
Evolving Landscape of Targeted Therapies
FEATURING
Lizza Hendriks
- 81 views
- October 29, 2024